MEDP · Insider Trading
Medpace Holdings, Inc. Common Stock
Every open-market purchase and sale reported by MEDP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-14 | Susan E Burwig | Exec. VP, Operations | M | +3,000 | +$500.19K |
| 2026-10-09 | Susan E Burwig | Exec. VP, Operations | M | +2,000 | +$333.46K |
| 2026-10-02 | Cornelius P. McCarthy III | Director | M | +28 | — |
| 2026-10-02 | Robert O. Kraft | Director | M | +32 | — |
| 2026-10-02 | Brian T Carley | Director | M | +36 | — |
| 2026-10-01 | August J. Troendle | President & CEO | Sell | −48,667 | −$30.32M |
| 2026-09-29 | August J. Troendle | President & CEO | Sell | −2,564 | −$1.59M |
| 2026-09-25 | August J. Troendle | President & CEO | Sell | −43,916 | −$27.40M |
| 2026-09-23 | August J. Troendle | President & CEO | Sell | −70,901 | −$44.43M |
| 2026-09-21 | August J. Troendle | President & CEO | Sell | −10,880 | −$6.75M |
| 2026-09-17 | Susan E Burwig | Exec. VP, Operations | M | +3,000 | +$500.19K |
| 2026-09-17 | August J. Troendle | President & CEO | Sell | −24,741 | −$15.36M |
| 2026-08-31 | August J. Troendle | President & CEO | Sell | −650 | −$403.18K |
| 2026-08-28 | Robert O. Kraft | Director | MIXED | — | −$2.06M |
| 2026-08-27 | August J. Troendle | President & CEO | Sell | −4,673 | −$2.90M |
| 2026-08-25 | August J. Troendle | President & CEO | Sell | −15,978 | −$9.97M |
| 2026-08-24 | Kevin M. Brady | CFO & Treasurer | MIXED | — | −$1.65M |
| 2026-08-21 | Brian T Carley | Director | Sell | −5,000 | −$3.04M |
| 2026-08-21 | Fred B Davenport Jr | Director | MIXED | +300 | −$3.53M |
| 2026-08-21 | August J. Troendle | President & CEO | Sell | −42,783 | −$26.28M |
| 2026-08-14 | August J. Troendle | President & CEO | Sell | −11,824 | −$7.11M |
| 2026-08-13 | Cornelius P. McCarthy III | Director | Sell | −1,140 | −$690.12K |
| 2026-08-12 | August J. Troendle | President & CEO | Sell | −23,144 | −$13.98M |
| 2026-08-11 | Cornelius P. McCarthy III | Director | MIXED | +3,063 | −$139.67K |
| 2026-07-29 | Susan E Burwig | Exec. VP, Operations | Sell | −7,500 | −$4.50M |
| 2026-07-29 | August J. Troendle | President & CEO | Sell | −7,238 | −$4.35M |
| 2026-07-02 | Cornelius P. McCarthy III | Director | M | +28 | — |
| 2026-07-02 | Brian T Carley | Director | M | +36 | — |
| 2026-07-02 | Robert O. Kraft | Director | M | +33 | — |
| 2026-06-01 | Stephen P Ewald | General Counsel & Corp. Secy. | MIXED | — | −$5.09M |
| 2026-05-18 | Brian T Carley | Director | A | — | — |
| 2026-05-18 | Fred B Davenport Jr | Director | A | — | — |
| 2026-05-18 | Femida H. Gwadry-Sridhar | Director | A | +1,110 deriv. | — |
| 2026-05-18 | Robert O. Kraft | Director | A | — | — |
| 2026-05-18 | Cornelius P. McCarthy III | Director | A | — | — |
| 2026-05-18 | Dani S. Zander | Director | A | +1,110 deriv. | — |
| 2026-04-28 | Kevin M. Brady | CFO & Treasurer | M | +7,000 | +$972.09K |
| 2026-04-28 | Susan E Burwig | Exec. VP, Operations | A | — | — |
| 2026-04-28 | Stephen P Ewald | General Counsel & Corp. Secy. | M | +3,500 | +$486.05K |
| 2026-04-28 | August J. Troendle | CEO | A | — | — |
| 2026-04-02 | Brian T Carley | Director | M | +36 | — |
| 2026-04-02 | Robert O. Kraft | Director | M | +33 | — |
| 2026-04-02 | Cornelius P. McCarthy III | Director | M | +29 | — |
| 2026-03-19 | Jesse J Geiger | President | MIXED | — | −$10.03M |
| 2026-03-19 | Susan E Burwig | Exec. VP, Operations | M | +12,000 | +$2.00M |
| 2026-02-18 | Stephen P Ewald | General Counsel & Corp. Secy. | M | +3,500 | +$486.05K |
| 2026-02-17 | Susan E Burwig | Exec. VP, Operations | M | +10,984 | +$1.19M |
| 2026-02-17 | Brian T Carley | Director | M | +6,472 | +$355.90K |
| 2026-01-05 | Brian T Carley | Director | M | +62 | — |
| 2026-01-05 | Robert O. Kraft | Director | M | +56 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| August J. Troendle | President & CEO | 5,071,244 | $3.36B |
| Susan E Burwig | Exec. VP, Operations | 70,984 | $47.03M |
| Jesse J Geiger | President | 46,707 | $30.94M |
| Stephen P Ewald | General Counsel & Corp. Secy. | 36,692 | $24.31M |
| Brian T Carley | Director | 27,861 | $18.46M |
| Kevin M. Brady | CFO & Treasurer | 16,230 | $10.75M |
| Cornelius P. McCarthy III | Director | 12,303 | $8.15M |
| Fred B Davenport Jr | Director | 11,259 | $7.46M |
| Robert O. Kraft | Director | 987 | $653.87K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MEDP quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.